You clearly can't or didn't bother to read. I wasn't suggesting a class action coming. We were actually discussions PR's long alluded partnerships finally not just being the surrepticiuous pump of the last 4 years and actually being of substance, given the more overt and formal guidance given and suggesting if they did they not ensue, a class action might ensue on very overt and very public guidance given. If you are intent on arguing perhaps read first.
No class action is likely coming. A partnership is more likely coming, given FDA clearance, at long last, given the more formal forums and more specific/deliberate form in which the partnership guidance given.
PAR Price at posting:
23.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)